Literature DB >> 17823815

Outcome of paediatric intensive care survivors.

Hendrika Knoester1, Martha A Grootenhuis, Albert P Bos.   

Abstract

The development of paediatric intensive care has contributed to the improved survival of critically ill children. Physical and psychological sequelae and consequences for quality of life (QoL) in survivors might be significant, as has been determined in adult intensive care unit (ICU) survivors. Awareness of sequelae due to the original illness and its treatment may result in changes in treatment and support during and after the acute phase. To determine the current knowledge on physical and psychological sequelae and the quality of life in survivors of paediatric intensive care, we undertook a computerised comprehensive search of online databases for studies reporting sequelae in survivors of paediatric intensive care. Studies reporting sequelae in paediatric survivors of cardiothoracic surgery and trauma were excluded, as were studies reporting only mortality. All other studies reporting aspects of physical and psychological sequelae were analysed. Twenty-seven studies consisting of 3,444 survivors met the selection criteria. Distinct physical and psychological sequelae in patients have been determined and seemed to interfere with quality of life. Psychological sequelae in parents seem to be common. Small numbers, methodological limitations and quantitative and qualitative heterogeneity hamper the interpretation of data. We conclude that paediatric intensive care survivors and their parents have physical and psychological sequelae affecting quality of life. Further well-designed prospective studies evaluating sequelae of the original illness and its treatment are warranted.

Entities:  

Mesh:

Year:  2007        PMID: 17823815      PMCID: PMC2039787          DOI: 10.1007/s00431-007-0573-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


Introduction

The development of paediatric intensive care has contributed to improved survival rates in children with critical illnesses [68, 69]. Consequently, new disease patterns have emerged due to long-term complications and effects of the original illness and its treatment. In addition to survival and morbidity, physical and psychological sequelae, as well as the quality of life (QoL) in survivors and in their families are important outcome measures. Historically, outcome research in paediatrics is either based on an age-specific approach, such as follow-up studies of premature infants [41, 72, 73], or on a more disease-oriented approach, such as follow-up studies in survivors of cardiothoracic surgery or trauma [15, 55, 64, 70]. These studies have shown substantial physical, psychological and neuro-cognitive sequelae, interfering with daily life and normal development. In addition, effects on parents and siblings have been shown [26]. Evaluative research of adult intensive care survivors showed the effect of intensive care treatment per se. Irrespective of the underlying illnesses, sequelae on all domains with effects on QoL were found [2, 19, 58, 75]. In multi-disciplinary paediatric intensive care unit (PICU) populations, reports on outcome are scarce [24, 25]. Based on these observations, we believe that follow-up research of paediatric intensive care survivors and their families is needed to evaluate: (1) physical sequelae and their impact during growth and development; (2) psychological sequelae in patients and their families and their impact on the QoL of patients and family members; and (3) the need for treatment and support after discharge. The aim of this article is to provide an overview of the available literature concerning the different domains of QoL (i.e. physical, psychological and social functioning) in children surviving paediatric intensive care, including the effect on parents, and to suggest directions for future follow-up research.

Methods

To identify studies eligible for this review, we searched Medline (1966–2006), EMBASE (1974–2006), CINAHL (1982–2006), pre-CINAHL and the Cochrane Library (2006) in March 2006. In the search strategy, all terms mapped to the appropriate MeSH/EMTREE subject headings and “exploded” were used; among them were: paediatric intensive care unit (PICU), septic shock, respiratory insufficiency, meningococcal disease, central venous catheterisation, intubation, physical and psychological sequelae, post-traumatic stress disorder (PTSD), QoL, health status and long-term outcome.

Definitions

Functional health is defined as an individual’s ability to perform normal daily activities, to fulfil usual roles and to maintain health and well-being. QoL is defined as an individual’s perception of their position in life, in the context of the culture and value systems and in relation to their goals, expectations, standards and concerns [1]. Health-related QoL (HRQoL) is defined as QoL in which a dimension of personal judgement over one’s health and disease is added [21].

Study selection

Studies were selected for review if they met two inclusion criteria: (1) study of a representative population of PICU survivors (defined as a population consisting of medical and/or surgical PICU patients <18 years old) and (2) evaluation of physical sequelae, measurement of QoL or functional health >30 days after PICU discharge. Because of the limited number of studies, the measurement tools did not need to be standardised. Studies with a retrospective and prospective design were included. Excluded were: (1) studies in homogeneous PICU populations (e.g. survivors of cardiothoracic surgery and trauma) reporting diagnosis-related outcome in particular but not intensive care treatment as such, and (2) studies evaluating mortality only.

Results

Eligible studies and quality of the studies

Twenty-seven studies were found in which one or more aspects of long-term sequelae in PICU survivors and/or their families were described. The patient characteristics, populations, measurement tools and outcomes are described in Tables 1 and 2. The quality criteria are described in Table 3. None of the studies met all of the quality criteria. In studies describing the same outcome aspect, differences in study population, follow-up time and measurement tools make the comparison and synthesis of results difficult.
Table 1

Patient characteristics, measurement tools, physical and functional health outcome

ReferencePopulationa, n b Agec (yrs)Follow-up timed (yrs)Severity of illnesse LOSf (days)Measurement toolOutcome (n)g Interpretation of outcome
23 Meningococcal disease0.1–15.38–12GMSPSNANeurological examination1 spastic quadriplegiaMajority of children surviving meningococcal disease neurologically normal.
n = 115 (139)Median 5Cognitive tests5 hearing loss
4 major impairments
35 Cardiopulmonary resuscitation (CPR)0–161NANAPCPCh 26 normal, 12 mild, 7 moderate, 3 severe disability60% of survivors of CPR neurological normal.
n = 44 (48)37 same as prior to CPRLocation, underlying cause and duration of CPR determinants of outcome.
43 CPR0–171NANAPCPCh 54 normal or mild disability, 6 moderate, 5 severe disability80% of survivors of CPR neurological normal.
n = 65 (94)POPCi Location, underlying cause and duration of CPR not determinants of outcome.
53 Acquired brain injury<3>0.5GCS<9NAGOSj GOS: 23 good recovery, 7 moderate, 5 severe disabilityMajority of children with acquired brain injury dead or disabled.
n = 38 (53)BSID-IIk BSID-II: 8 normal, 12 cerebral palsy, 11 cognitive delay
Neuro-developmental examination
59 CPR0–181NAPICUPCPCh 5 normal, 1 mild, 4 moderate, 1 severe disability, 2 persistent vegetative state38% of survivors of CPR neurological normal.
n = 13Median 5POPCi Underlying cause and duration of CPR determinants of outcome.
6 ARDS2–135.6±4.3NANAChest radiography1 SaO2 94% during exerciseARDS survivors at risk for hypoxaemia during exercise.
n = 7 (15)Pulmonary function1 reduced diffusion capacity
14 Meningococcal disease with ARDS0.3–3.70.5–2.1PRISM 12-53%NAPulmonary function1 wheezing for which salbutamolARDS survivors possibly at risk for mild obstructive lung disease.
n = 122 obstructive disease
22 ARDS4.6–15.90.9–4.2NANAPulmonary function3 restrictive or obstructive diseaseARDS survivors at risk for restrictive and obstructive lung disease.
n = 9 (12)Electrocardiography EchocardiographyCardiac function normal in all
30 ARDS5–144.4NANAPulmonary function1 limitations in activityARDS survivors at risk for restrictive and obstructive lung disease.
n = 54 restrictive disease
48 Meningococcal septic shock1.6–15.42.2–4.9NANAPulmonary function18 normal lung functionMeningococcal septic shock survivors at risk for hypoxaemia during exercise.
n = 186 SaO2≤95% during exercise
74 ARDS0.5–160.3–5.5PRISM 18±14%NAChest radiography7 (11) restrictive or obstructive diseaseARDS survivors at risk for restrictive and obstructive lung disease.
n = 14 (20)Pulse oximetry4 (7) decreased diffusion capacity
Pulmonary function
Electrocardiography
Echocardiography
62 Meningococcal sepsis with renal replacement therapy0.5–152.7–7.1NAPICUGlomerular filtration rate (GFR)2 decreased GFR, proteinuria, hypertensionChildren surviving acute renal failure due to septic shock at risk for long-term renal dysfunction.
n = 12 (15)Median 12Serum creatinine1 parenchymal defect
Protein excretion in urine1 proteinuria
DMSA scan
9 Near drowning admitted to PICU0.7–14≥0.5PRISM 71%NAFunctional health:8 severe neurological impairmentMajority of near-drowning survivors lead a normal life.
n = 25 (27)GCS≤5Contact primary physician or examination by study facility17 normal or mildly impaired
12 PICU0–182.5–3NAPICUFunctional health:7% moderate or severe handicapMajority of PICU survivors seem to lead a normal life.
n = 775Mean 2.8Written questionnaire or telephone contact with the specialist physician or parents12% mild handicap
91% will lead independent life
44 Bacterial meningitis with respiratory insufficiency0–120.6–6.4PRISMNAFunctional health:12 normalHalf of children surviving severe bacterial meningitis seem to lead a normal life.
n = 21 (22)Mean 22%Telephone interview1 independent
Range 1–47%2 partially dependent
6 dependent

aStudied population. b n = studied patients (eligible patients). cAge of patients at admission to PICU (mean±SD or range). dFollow-up time (mean±SD or range). eSeverity of illness (PRISM, Glasgow Coma Score (GCS), Glasgow Meningococcal Septicaemia Prognostic Score (GMSPS) and/or parent rating). fLength of stay (LOS) in PICU and/or hospital (mean±SD or range). g n= examined patients (eligible patients)

hPCPC=Paediatric Cerebral Performance Category. iPOPC=Paediatric Overall Performance Category. jGOS=Glasgow Outcome Scale. kBSID-II=Bayley Scales of Infant Development-II

Table 2

Patient characteristics, measurement tools and psychological and quality of life (QoL) outcome

ReferencePopulationa, n b Agec (yrs)Follow-up timed (yrs)Severity of illnesse LOSf (days)Measurement toolOutcome (n)g Interpretation of outcome
40 PICU children and mothers2.1–15.90.3–1PRISM 0.4–76%PICU 1–30Psychological outcome:Children: Behaviour high 3 (8), SDQ high 3 (21), IES PTSD 3 (29)PICU survivors and their mothers at risk for psychological distress and PTSD.
n = 29 (33)Child: Behaviour Check List, SDQh,IESi Mothers: GHQ high 11 (26), IES high 13 (27)
Mother: GHQj, IESi
50 PICU5–18Median 0.6Parent rating 10Hospital 4–14Psychological outcome:Children: PTSD 4 (19) PICU, 0 (27) ward IES high 4 (21) PICU, 2 (17) wardPICU survivors and their parents at risk for psychological distress and PTSD.
n = 35 (46)Child: PTSDk, SDQh, IESi, depression, anxiety, CSIl Parents: PTSD 9(33) PICU, 2 (29) ward
General wardParent: GHQj, IESi depression
n = 33 (41)
Children and parents
51 PICU11.3±3.20.5PRISM 25±23%Hospital 13.0Psychological outcome:IES and CMFS dependent on invasive procedures, CMFS and CHLOC on ageStress symptoms in children possibly dependent on number of invasive procedures.
n = 60 (69)Children: IESi, CMFSm, CHLOCn
General ward
n = 60 (69)
52 PICUMean0.5PRISMNAPsychological outcome:IES higher in high risk, not decreasing over time, IES related with invasive proceduresStress symptoms possibly dependent on invasive procedures. Stress symptoms not decreasing over time.
n = 60Low risk 11.5Low risk<34%Children: IESi, CMFSm, CHLOCn
High risk 11.1High risk≥34%
61 Meningococcal disease PICU and wardMedian 6.80.3GMSPS 6.9±3.3PICU LOS 0–62Psychological outcome:Child: PTSD 4 (26)PICU survivors and their parents at risk for psychological distress and PTSD.
Children and parentsParent rating median 7Hospital LOS 2–87Child: SDQh, IESi Mothers: PTSD 22 (58)
n = 78 (118)Parent: GHQj, IESi Fathers: PTSD 8 (43)
4 PICU parents25% <1, 25% 1–4, 25% 5–11, 25% >110.2–0.9PRISM 0–26%PICU 1–200Psychological outcome:ASD 87Parents of PICU survivors with ASD more at risk for PTSD.
n = 272 (291)Parent rating 1–9Parents: Acute Stress Disease symptomsPTSD 33
PTSDk symptoms
8 PICU1.2±1.3<0.5PRISM 12±7%PICU 10.5±11.5Psychological outcome mothers:Mothers PICU more stress. Stress decreases over time in all groupsMothers of PICU survivors at risk for psychological distress; families at risk for dysfunctioning.
n = 31Parent rating 8.3±1.9Parental Stress Scale SCL-90-Ro All families dysfunctioning
General wardFAM IIIp
n = 32FILEq
ER
n = 32 Mothers
20 Meningococcal Disease Parents1–180.25–7NANAPsychological outcome parents:High psychological distress in mothers and fathers, not decreasing over timeMothers and fathers of PICU survivors at risk for psychological distress.
102 mothers, 90 fathersGHQj
27 PICU4.61PRISMNAQoL: MAHSCr 106 equal to before PICU50% of PICU survivors seem to have the same QoL as before admission; 10% normal QoL.
n = 226 (241) n = 223 < 5%58 improved
n = 19 > 16%62 deteriorated
26 normal
38 PICU5.7±3.61PRISMPICU 5.7±5.5QoL: MAHSCr 52 improved50% of PICU survivors seem to have good QoL.
n = 138 (150) n = 79 < 5%29 deteriorated
n = 4 > 16%65 normal after PICU
47 PICUMedian 2.30.3–2PRISMNAQoL: RAHCs measure of function256 normal QoL60% of PICU survivors seem to have normal QoL.
n = 432 (906)Mean 5.5%140 fair QoL
9 poor QoL
65 PICU0–29.32.3–6PRISMPICU 0–57.4QoL: HSUIt GOSu HSUI (727): 608 normal, 29 (very) poor QoL70% of PICU survivors seem to have good QoL.
n = 868 (1265) n = 554 < 5%GOS (727): 515 normal, 137 mild disability, 75 moderate/severe disability60% seem to have normal functional health.
n = 137 > 16%

aStudied population. b n = studied patients (eligible patients). cAge of patients at admission to PICU (mean±SD or range). dFollow-up time (mean±SD or range). eSeverity of illness (PRISM, Glasgow Coma Score, GMSPS and/or parent rating). fLength of stay (LOS) in PICU and/or hospital (mean±SD or range). g n = examined patients (eligible patients).

hSDQ=Strength and Difficulties Questionnaire. iIES=Impact of Event Scale. jGHQ=General Health Questionnaire. kPTSD=Post-traumatic stress disorder. lCSI=Child Somatization Inventory. mCMFS=Child Medical Fears Scale. nCHLOC=Child Health Locus Control Scale.oSCL-90-R=Symptom Checklist-90 Revised. pFAM III=Family Assessment Measure III. qFILE=Family Inventory of Life Events and Change. rMAHSC=Multi-attribute health status classification. sRAHC=Royal Alexandra Hospital for Children. tHSUI=Health State Utility index. uGOS=Glasgow Outcome Score

Table 3

Quality assessment of reviewed studies

ReferenceSelection bias excludeda Selective loss to follow-up excludedb Exposure clearly definedc Outcome clearly definedd Control group includede
4 yesyesyesyesno
6 nonoyesyesno
8 nonoyesyesyes
9 noyesyesnono
12 yesyesyesyesno
14 yesyesyesyesno
20 yesyesyesyesno
22 nononoyesno
23 nonoyesyesyes
27 yesnoyesyesno
30 nononoyesno
35 yesnoyesyesno
38 nonoyesyesno
40 noyesyesyesno
43 nonoyesyesno
44 yesyesyesyesno
47 yesnoyesyesno
48 nonoyesyesno
50 yesnoyesyesyes
51 noyesyesyesyes
52 noyesyesyesyes
53 yesyesyesyesno
59 yesnoyesyesno
61 noyesyesyesno
62 yesnoyesyesno
65 nonoyesyesno
74 yesyesyesyesno

aSelection bias excluded (i.e. exclusion of >10% of the studied population excluded). bSelective loss to follow-up excluded (i.e. description of patients lost to follow-up and comparison with those remaining in the study). cExposure clearly defined (i.e. clear definition of the studied population). dOutcome clearly defined (i.e. clear definition of outcome measures). eComparison with control group (i.e. children admitted to general ward)

Patient characteristics, measurement tools, physical and functional health outcome aStudied population. b n = studied patients (eligible patients). cAge of patients at admission to PICU (mean±SD or range). dFollow-up time (mean±SD or range). eSeverity of illness (PRISM, Glasgow Coma Score (GCS), Glasgow Meningococcal Septicaemia Prognostic Score (GMSPS) and/or parent rating). fLength of stay (LOS) in PICU and/or hospital (mean±SD or range). g n= examined patients (eligible patients) hPCPC=Paediatric Cerebral Performance Category. iPOPC=Paediatric Overall Performance Category. jGOS=Glasgow Outcome Scale. kBSID-II=Bayley Scales of Infant Development-II Patient characteristics, measurement tools and psychological and quality of life (QoL) outcome aStudied population. b n = studied patients (eligible patients). cAge of patients at admission to PICU (mean±SD or range). dFollow-up time (mean±SD or range). eSeverity of illness (PRISM, Glasgow Coma Score, GMSPS and/or parent rating). fLength of stay (LOS) in PICU and/or hospital (mean±SD or range). g n = examined patients (eligible patients). hSDQ=Strength and Difficulties Questionnaire. iIES=Impact of Event Scale. jGHQ=General Health Questionnaire. kPTSD=Post-traumatic stress disorder. lCSI=Child Somatization Inventory. mCMFS=Child Medical Fears Scale. nCHLOC=Child Health Locus Control Scale.oSCL-90-R=Symptom Checklist-90 Revised. pFAM III=Family Assessment Measure III. qFILE=Family Inventory of Life Events and Change. rMAHSC=Multi-attribute health status classification. sRAHC=Royal Alexandra Hospital for Children. tHSUI=Health State Utility index. uGOS=Glasgow Outcome Score Quality assessment of reviewed studies aSelection bias excluded (i.e. exclusion of >10% of the studied population excluded). bSelective loss to follow-up excluded (i.e. description of patients lost to follow-up and comparison with those remaining in the study). cExposure clearly defined (i.e. clear definition of the studied population). dOutcome clearly defined (i.e. clear definition of outcome measures). eComparison with control group (i.e. children admitted to general ward)

Physical and neuro-cognitive sequelae (Table 1)

In 12 studies that included in total 340 patients, aspects of physical and neuro-cognitive sequelae were evaluated. Neurological evaluation was conducted in five studies including 275 survivors. The majority of the children were neurologically normal. In the remaining children, disabilities such as hearing loss, coordination, cognition and developmental problems turned out to be severe [23, 35, 43, 53, 59]. Pulmonary evaluation was conducted in six studies including 65 patients [6, 14, 22, 30, 48, 74]. Restrictive and obstructive disease and hypoxaemia during exercise was found. Cardiac evaluation was conducted in two studies including 23 survivors [22, 74]. No abnormalities were found, except for left ventricular hypertrophy in one child. Renal evaluation was conducted in one study including 12 survivors [62]. In two children, glomerular filtration was impaired, one had hypertension and one had proteinuria.

Psychological sequelae (Table 2)

Various questionnaires were used. Cut-off points for the diagnosis of PTSD differed between studies but all of them showed high scores for PTSD in children and parents. Psychological evaluation of children was conducted in five studies including 202 children [40, 50–52, 61]. Symptoms of PTSD were found in 11 of 74 evaluated children. In one study, a relation was found between invasive procedures and high scores [52]. Psychological evaluation of parents was conducted in six studies including parents of 547 children [4, 8, 20, 40, 50, 61]. Symptoms of PTSD were found in 72 of 295 evaluated parents. In some studies, a relation was found between high scores and illness severity as perceived by parents [4, 50, 61]. In one study, these high scores decreased over time [8].

Functional health and QoL (Tables 1 and 2)

Evaluation of functional health was conducted in three studies including 821 children [9, 12, 44]. The majority of the children seemed to have normal functional health; the remainder was found to be seriously impaired. Evaluation of QoL was conducted in four studies including 1,664 children [27, 38, 47, 65]. QoL was evaluated using three different questionnaires. In the majority of children, the QoL was normal or equal to the QoL before PICU admission. In all studies, some of the children had poor QoL.

Discussion

Only 27 studies consisting of 3,444 PICU survivors met our inclusion criteria. The small numbers, heterogeneity of the studied populations and the used measurement tools, the frequent use of non-validated measurement tools and the various aspects of outcomes studied make aggregation of the data and, therefore, strong conclusive statements difficult.

Physical sequelae

The reviewed studies report distinct physical sequelae, including neurological abnormalities in PICU survivors. Standardised neurological examination of PICU survivors was validated in 1994 but very few studies have been carried out since [24, 25]. As neurological problems have a great impact on daily life, standardised evaluation and adequate support and rehabilitation seem to be relevant, similar to in NICU survivors [11, 46, 56]. Follow-up studies evaluating lung function in children are hampered by the small incidence of severe respiratory insufficiency in children [49]. In adult respiratory distress syndrome (ARDS), the recovery of lung function is shown during the first year and physical limitations seem to be partly dependent on lung function [34, 58]. In infants and children, post-natal lung growth may contribute to the improvement of lung function after critical illness. In addition to lung function, the long-term effect of small airway disease should be evaluated, for instance, in children with respiratory syncitial virus infection. Data on the structured evaluation of cardiac and renal function in paediatric and adult ICU survivors is not available. In young children, septic shock and the need for vasoactive support of the circulation may interact with the developing myocardium and may have persistent effects on cardiac growth and function [10, 67, 77]. Complications of intensive care procedures per se, (e.g. vascular complications due to intra-vascular catheters and side-effects of ototoxic drugs and sedatives) are not evaluated [5, 18, 32, 33, 45, 54, 57, 63]. One can assume the exact incidence of physical sequelae to be higher than has been reported so far.

Psychological sequelae and functional health and QoL

In the reviewed studies, psychological sequelae have been established in 10–14% of survivors and their parents. The comparison of findings is hampered due to different measurement tools and cut-off points for the diagnosis of PTSD and various follow-up intervals. Risk factors accounting for hampered psychological outcome could be diverse (severity of illness, being removed from one’s child, having been witness to the accident, mental health, family functioning, social support, coping strategies and lack of information from the medical team) [17, 26, 29, 31]. Psychological support to improve coping strategies and prevent over-protection might improve psychological outcome in children and parents [3, 28]. Further research is essential to establish the appropriate time and extent of the psychological support needed. Cognitive sequelae have rarely been studied in the reviewed studies. Adequate neuro-cognitive evaluation is both expensive and time-consuming. Studies in neonatal ICU survivors show substantial cognitive dysfunction with great impact on daily life [7]. Consequently, early intervention, education and rehabilitation are expected to improve daily life [11, 46]. A majority of PICU survivors seem to have unchanged functional health and good QoL. In the reviewed studies, functional health is evaluated by telephone interviews [27, 38, 47, 65]. In most of these studies, the physician rather than the child or its parents evaluates functional health. Ideal (HR)QoL questionnaires should measure all aspects of QoL and preferably be filled in by the children themselves. Proxy investigation of functional health and (HR)QoL (in children <6–8 years of age) is second best [36, 37, 39, 66]. Besides, the pre-morbid state is probably an important factor which is difficult to assess [16].

Suggestions for future follow-up research

The reviewed studies have a number of methodological limitations. Heterogeneity is the most important one. Consensus on all aspects of follow-up research is essential for well-founded conclusions. For example, structured and standardised evaluation of: (1) organ system function with a validated tool such as the Paediatric Logistic Organ Dysfunction (PELOD) score [13, 42, 60, 71]; (2) neuro-cognitive function; (3) complications of PICU treatment; and (4) (HR)QoL are warranted. Multi-centre studies as proposed by the Collaborative Pediatric Critical Care Research Network (CPCCRN) with a uniform approach will provide answers either in general PICU cohorts or in disease-oriented study groups [76]. In conclusion, this review indicates that PICU survivors and their parents may have substantial physical and psychological sequelae interacting with QoL. Because of longer life expectancy, longer follow-up time is warranted, emphasising the consequences for health care in children. We believe that paediatric intensivists and psychologists should be involved as core members of follow-up teams.
  75 in total

1.  Surviving intensive care: a report from the 2002 Brussels Roundtable.

Authors:  Derek C Angus; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-01-21       Impact factor: 17.440

Review 2.  Adverse responses: sedation, analgesia and neuromuscular blocking agents in critically ill children.

Authors:  Lauren R Sorce
Journal:  Crit Care Nurs Clin North Am       Date:  2005-12       Impact factor: 1.326

3.  Acquired total (grade 4) subglottic stenosis in children.

Authors:  L M Gustafson; B E Hartley; R T Cotton
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-01       Impact factor: 1.547

Review 4.  Outcome evaluations as measures of quality in pediatric intensive care.

Authors:  D H Fiser
Journal:  Pediatr Clin North Am       Date:  1994-12       Impact factor: 3.278

5.  Neurodevelopmental outcome in meningococcal disease: a case-control study.

Authors:  J M Fellick; J A Sills; O Marzouk; C A Hart; R W Cooke; A P Thomson
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

6.  Long-term outcome of meningococcal sepsis-associated acute renal failure.

Authors:  Rachael Slack; Kay C Hawkins; Louise Gilhooley; G Michael Addison; Malcolm A Lewis; Nicholas J A Webb
Journal:  Pediatr Crit Care Med       Date:  2005-07       Impact factor: 3.624

7.  How well do parents know their children? Implications for proxy reporting of child health-related quality of life.

Authors:  A Jokovic; D Locker; G Guyatt
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

8.  Early intervention in low birth weight premature infants: results at 18 years of age for the Infant Health and Development Program.

Authors:  Marie C McCormick; Jeanne Brooks-Gunn; Stephen L Buka; Julie Goldman; Jennifer Yu; Mikhail Salganik; David T Scott; Forrest C Bennett; Libby L Kay; Judy C Bernbaum; Charles R Bauer; Camilia Martin; Elizabeth R Woods; Anne Martin; Patrick H Casey
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

9.  Respiratory and cardiac function in children after acute hypoxemic respiratory failure.

Authors:  I Weiss; H M Ushay; W DeBruin; J O'Loughlin; I Rosner; D Notterman
Journal:  Crit Care Med       Date:  1996-01       Impact factor: 7.598

10.  Collaborative Pediatric Critical Care Research Network (CPCCRN).

Authors:  Douglas F Willson; J Michael Dean; Christopher Newth; Murray Pollack; K J S Anand; Kathleen Meert; Joseph Carcillo; Jerry Zimmerman; Carol Nicholson
Journal:  Pediatr Crit Care Med       Date:  2006-07       Impact factor: 3.624

View more
  21 in total

1.  Attributable Delay of Discharge for Children with Long-Term Mechanical Ventilation.

Authors:  Sarah A Sobotka; Carolyn Foster; Emma Lynch; Lindsey Hird-McCorry; Denise M Goodman
Journal:  J Pediatr       Date:  2019-05-29       Impact factor: 4.406

Review 2.  Health-related quality of life following pediatric critical illness.

Authors:  François Aspesberro; Rita Mangione-Smith; Jerry J Zimmerman
Journal:  Intensive Care Med       Date:  2015-04-08       Impact factor: 17.440

Review 3.  Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  R Scott Watson; Sheri S Crow; Mary E Hartman; Jacques Lacroix; Folafoluwa O Odetola
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

Review 4.  Staffing and workforce issues in the pediatric intensive care unit.

Authors:  Derek S Wheeler; Maya Dewan; Andrea Maxwell; Carley L Riley; Erika L Stalets
Journal:  Transl Pediatr       Date:  2018-10

5.  Anxiety and worry when coping with cancer treatment: agreement between patient and proxy responses.

Authors:  Ana Paula Hermont; Ana Carolina Scarpelli; Saul M Paiva; Sheyla M Auad; Isabela A Pordeus
Journal:  Qual Life Res       Date:  2014-12-02       Impact factor: 4.147

6.  The Burden of Pediatric Neurocritical Care in the United States.

Authors:  Cydni N Williams; Juan Piantino; Cynthia McEvoy; Nora Fino; Carl O Eriksson
Journal:  Pediatr Neurol       Date:  2018-08-04       Impact factor: 3.372

7.  Parental Conflict, Regret, and Short-term Impact on Quality of Life in Tracheostomy Decision-Making.

Authors:  Tessie W October; Amy H Jones; Hannah Greenlick Michals; Lauren M Hebert; Jiji Jiang; Jichuan Wang
Journal:  Pediatr Crit Care Med       Date:  2020-02       Impact factor: 3.624

8.  Transforming PICU Culture to Facilitate Early Rehabilitation.

Authors:  Ramona O Hopkins; Karen Choong; Carleen A Zebuhr; Sapna R Kudchadkar
Journal:  J Pediatr Intensive Care       Date:  2015-12

9.  Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial.

Authors:  Reid W D Farris; Noel S Weiss; Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2013-11       Impact factor: 3.624

10.  Neuropsychological function in children following admission to paediatric intensive care: a pilot investigation.

Authors:  Sarah Elison; Dan Shears; Simon Nadel; Barbara Sahakian; M Elena Garralda
Journal:  Intensive Care Med       Date:  2008-04-05       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.